The congress offers six different tracks focusing on drug discovery, development and implementation.
Details of which can be found here and here. Track E focuses on the practice of science-based pharmacy, which will soon see major changes. Individualised treatments will be a significant part of clinical practice and we will be able to use “big data” for post-marketing medicines evaluation. Symposia will include: “Clinical implementation of precision medicine: From genome-wide discovery to practice”; “Impact of pharmacy practice research on patient outcomes”; “Medicines for the real-life population: the science of extrapolation”; and “Big data, real world evidence and regulatory science”.